APA

Liu H., Ertay A., Peng P., Li J., Liu D., Xiong H., Zou Y., Qiu H., Hancock D., Yuan X., Huang W., Ewing R. M., Downward J. & Wang Y. (20200430). SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. : Molecular oncology.

Chicago

Liu Huiquan, Ertay Ayse, Peng Ping, Li Juanjuan, Liu Dian, Xiong Hua, Zou Yanmei, Qiu Hong, Hancock David, Yuan Xianglin, Huang Wei-Chien, Ewing Rob M, Downward Julian and Wang Yihua. 20200430. SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. : Molecular oncology.

Harvard

Liu H., Ertay A., Peng P., Li J., Liu D., Xiong H., Zou Y., Qiu H., Hancock D., Yuan X., Huang W., Ewing R. M., Downward J. and Wang Y. (20200430). SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. : Molecular oncology.

MLA

Liu Huiquan, Ertay Ayse, Peng Ping, Li Juanjuan, Liu Dian, Xiong Hua, Zou Yanmei, Qiu Hong, Hancock David, Yuan Xianglin, Huang Wei-Chien, Ewing Rob M, Downward Julian and Wang Yihua. SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. : Molecular oncology. 20200430.